Compare PLNT & CRL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PLNT | CRL |
|---|---|---|
| Founded | 1992 | 1947 |
| Country | | |
| Employees | N/A | N/A |
| Industry | Hotels/Resorts | Biotechnology: Commercial Physical & Biological Resarch |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.1B | 7.8B |
| IPO Year | N/A | N/A |
| Metric | PLNT | CRL |
|---|---|---|
| Price | $92.30 | $158.55 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 11 | 12 |
| Target Price | $120.91 | ★ $205.27 |
| AVG Volume (30 Days) | ★ 1.6M | 927.1K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $21.61 | N/A |
| Revenue Next Year | $10.81 | $1.70 |
| P/E Ratio | $37.93 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $87.44 | $91.86 |
| 52 Week High | $114.47 | $228.88 |
| Indicator | PLNT | CRL |
|---|---|---|
| Relative Strength Index (RSI) | 42.70 | 24.03 |
| Support Level | $87.44 | $148.34 |
| Resistance Level | $92.75 | $218.69 |
| Average True Range (ATR) | 2.81 | 9.68 |
| MACD | 0.45 | -5.96 |
| Stochastic Oscillator | 67.12 | 14.56 |
Planet Fitness Inc is a franchisor and operator of fitness centers in the United States. The company's reportable segments are Franchise, Corporate-owned stores, and Equipment. Franchise segment includes operations related to its franchising business in the United States, Puerto Rico, Canada, Panama, Mexico and Australia, Corporate-owned stores segment includes operations with respect to all corporate-owned stores throughout the United States and Canada, and The Equipment segment includes the sale of equipment to franchisee-owned stores in the U.S. The firm generates a majority of its revenue from the Corporate-owned stores segment.
Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.